Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of cardiovascular diseases
3.2.1.2 Growing awareness of preventive healthcare
3.2.1.3 Increasing geriatric population
3.2.2 Industry pitfalls & challenges
3.2.2.1 Regulatory and quality assurance challenges
3.2.2.2 High cost associated with the testing services
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Regulatory landscape
3.6 Porter's analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Test Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Total cholesterol tests
5.3 High density lipoprotein (HDL) cholesterol tests
5.4 Low density lipoprotein (LDL) cholesterol tests
5.5 Triglyceride tests
5.6 Other tests
Chapter 6 Market Estimates and Forecast, By Product Type, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Testing kits
6.3 Testing strips
6.4 Other product types
Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Cardiovascular diseases
7.3 Diabetes
7.4 Obesity
7.5 Hyperlipidemia
7.6 Other applications
Chapter 8 Market Estimates and Forecast, By Age Group, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Geriatric
8.3 Adult
8.4 Pediatric
Chapter 9 Market Estimates and Forecast, By Service Provider, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 Hospitals and clinics
9.3 Diagnostic laboratories
9.4 Ambulatory care centers
9.5 Other service providers
Chapter 10 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
10.1 Key trends
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Netherlands
10.3.7 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Argentina
10.5.4 Rest of Latin America
10.6 Middle East and Africa
10.6.1 Saudi Arabia
10.6.2 South Africa
10.6.3 UAE
10.6.4 Rest of Middle East and Africa
Chapter 11 Company Profiles
11.1 Abbott Laboratories
11.2 Accu Reference Medical Lab, LLC
11.3 Atherotech Diagnostics Lab
11.4 Bio-Reference Laboratories, Inc.
11.5 Boston Heart Diagnostics Corporation
11.6 Cell Biolabs Inc.
11.7 Clinical Reference Laboratory, Inc.
11.8 Eurofins Scientific
11.9 Mayo Clinic Laboratories
11.10 Quest Diagnostics Incorporated
11.11 Randox Laboratories Limited
11.12 Sonic Healthcare Limited
11.13 SpectraCell Laboratories Inc.
11.14 SYNLAB Holding Deutschland GmbH
11.15 Thermo Fisher Scientific Inc.
